CalculatorCardiology
Sudden cardiac death risk in hypertrophic cardiomyopathy (HCM Risk-SCD)
Five-year probability of sudden cardiac death in hypertrophic cardiomyopathy to guide primary-prevention ICD decisions.
Updated 31 October 2026
When to use it
Adults (≥ 16 years) with hypertrophic cardiomyopathy and no prior cardiac arrest or sustained ventricular tachycardia.
Warning
Validated for wall thickness of 10–35 mm; outside that range the estimate is unreliable.
What it needs
- Age
- Maximal LV wall thickness
- Left atrial diameter (parasternal, M-mode or 2D)
- Maximal LVOT gradient (rest or Valsalva)
- Family history of sudden death (≥ 1 first-degree relative < 40 years or with HCM)
- Non-sustained ventricular tachycardia
- Unexplained syncope within the last 6 months
Formula
PI = 0.15939858 × MWT − 0.00294271 × MWT² + 0.0259082 × LA + 0.00446131 × gradient + 0.4583082 × FH SCD + 0.82639195 × NSVT + 0.71650361 × syncope − 0.01799934 × age
5-year risk = 1 − 0.998^exp(PI)
(MWT = maximal wall thickness in mm; LA = left atrial diameter in mm; maximal LVOT gradient in mmHg)
How to interpret it
| Result | Interpretation |
|---|---|
| < 4 | Low risk (< 4 %): ICD generally not indicated |
| 4 to < 6 | Intermediate risk (4–6 %): ICD may be considered |
| ≥ 6 | High risk (≥ 6 %): ICD should be considered |
Practical tip
Not applicable under 16 years (use HCM Risk-Kids), elite athletes, metabolic or infiltrative phenocopies (Fabry, amyloidosis, Noonan) or after myectomy or alcohol septal ablation.
2 more practical tips in the app.
Reference
- O'Mahony C, Jichi F, Pavlou M, et al. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD). Eur Heart J. 2014;35(30):2010-2020.
- Elliott PM, Anastasakis A, Borger MA, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy. Eur Heart J. 2014;35(39):2733-2779.
A support tool for healthcare professionals: it guides and does not replace clinical judgement.
